Id http://purl.obolibrary.org/obo/NCIT_C172063
http://purl.obolibrary.org/obo/NCIT_C172063
Preferred Name

Autologous Anti-CD20 CAR Transduced CD4/CD8 Enriched T-cells MB-CART20.1

Definitions
A preparation of autologous T-lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD20 (cluster of differentiation 20), and CD4/CD8 enriched, with potential immunostimulating and antineoplastic activities. Upon administration, MB-CART20.1 specifically recognize and kill CD20-expressing tumor cells. The CD20 antigen, a non-glycosylated cell surface phosphoprotein, is a B-cell specific cell surface antigen expressed in B-cell lineage malignancies and certain melanoma cell subpopulations.
Type http://www.w3.org/2002/07/owl#Class
Delete Subject Author Type Created
No notes to display